Stay in touch
Prime news from our network.
#read
Merz remains on course for growth at the Dessau-Roßlau site
The Merz company has put a new production line into operation at its Dessau-Roßlau site, continuing its growth trajectory. The investment of around 50 million euros in the sterile filling line was celebrated at a family summer party, which was also attended by Saxony-Anhalt's Minister President Dr Rainer Haseloff and numerous guests. With the expansion, Merz is emphasising its commitment to Saxony-Anhalt, which is considered one of the most innovative industrial locations in the state.
11/09/2024
Merz wants to continue to grow with new projects at the Biopharmapark Dessau-Roß. For example, a building for microbiological tests is currently being constructed to expand the biotechnology centre. Further projects to expand production and sales capacities are in the pipeline. Merz, a global healthcare company headquartered in Frankfurt am Main, has been producing high-quality aesthetic and neurological speciality products in Dessau since 2002. With the current and planned expansion measures, the company is focussing on particularly high-selling products that are used both in aesthetic medicine and for the treatment of neurological movement disorders.
The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.